Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 4
1977 8
1978 7
1979 6
1980 9
1981 7
1982 6
1983 12
1984 11
1985 12
1986 15
1987 14
1988 15
1989 23
1990 18
1991 27
1992 16
1993 25
1994 24
1995 21
1996 21
1997 17
1998 25
1999 13
2000 25
2001 16
2002 21
2003 12
2004 25
2005 27
2006 28
2007 19
2008 19
2009 20
2010 18
2011 11
2012 12
2013 15
2014 15
2015 11
2016 12
2017 15
2018 9
2019 9
2020 9
2021 8
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

688 results

Results by year

Filters applied: . Clear all
Page 1
Levodopa-Induced Dyskinesia in Parkinson's Disease: Pathogenesis and Emerging Treatment Strategies.
Kwon DK, Kwatra M, Wang J, Ko HS. Kwon DK, et al. Cells. 2022 Nov 23;11(23):3736. doi: 10.3390/cells11233736. Cells. 2022. PMID: 36496996 Free PMC article. Review.
Virtually all patients with PD undergo dopamine replacement therapy using levodopa during the course of the disease's progression. However, despite the fact that levodopa is the "gold standard" in PD treatments and has the ability to significantly alleviate PD symptoms, it …
Virtually all patients with PD undergo dopamine replacement therapy using levodopa during the course of the disease's progression. Ho …
Predicting levodopa-induced dyskinesia.
Kempster P. Kempster P. Arq Neuropsiquiatr. 2020 Apr;78(4):185-186. doi: 10.1590/0004-282X20200023. Arq Neuropsiquiatr. 2020. PMID: 32321051 Free article. No abstract available.
Tardive dyskinesia.
Casey DE. Casey DE. West J Med. 1990 Nov;153(5):535-41. West J Med. 1990. PMID: 1979705 Free PMC article. Review.
Drug-induced tardive dyskinesia.
Itoh H. Itoh H. Curr Dev Psychopharmacol. 1981;6:93-126. doi: 10.1007/978-94-011-8123-5_4. Curr Dev Psychopharmacol. 1981. PMID: 6112119 Review.
Drug-induced tardive dyskinesia, which occurs in the course of long-term administration of psychotropic drugs, especially neuroleptics, and persists for years even after drug removal, began to be reported in the late 1950s. ...The author presents a review of the symptomato …
Drug-induced tardive dyskinesia, which occurs in the course of long-term administration of psychotropic drugs, especially neuroleptic …
Tardive dyskinesia.
Jeste DV, Caligiuri MP. Jeste DV, et al. Schizophr Bull. 1993;19(2):303-15. doi: 10.1093/schbul/19.2.303. Schizophr Bull. 1993. PMID: 8100643 Review.
The advantages and limitations of the traditional rating scales and the newer instrumental approaches are discussed. The course of TD is variable but often not progressive. The early theory that striatal dopamine receptor supersensitivity causes TD has now given way to the …
The advantages and limitations of the traditional rating scales and the newer instrumental approaches are discussed. The course of TD …
Tardive dyskinesia.
Gerlach J, Casey DE. Gerlach J, et al. Acta Psychiatr Scand. 1988 Apr;77(4):369-78. doi: 10.1111/j.1600-0447.1988.tb05138.x. Acta Psychiatr Scand. 1988. PMID: 2898870 Review.
The traditional dopamine hypersensitivity theory is no longer viable, whereby new hypotheses have been advanced: TD can be due to the blockade of a subset of striatal dopamine receptors, while parkinsonism is due to the blockade of another such subset, and/or can be due to a redu …
The traditional dopamine hypersensitivity theory is no longer viable, whereby new hypotheses have been advanced: TD can be due to the blocka …
Drug-induced and tardive movement disorders.
Vernon GM. Vernon GM. J Neurosci Nurs. 1991 Jun;23(3):183-7. doi: 10.1097/01376517-199106000-00010. J Neurosci Nurs. 1991. PMID: 1831484 Review.
Management of patients with drug-induced or tardive syndromes is complex. Prognosis is frequently poor as patients usually need the offending agent to manage their underlying psychiatric or medical problem. ...
Management of patients with drug-induced or tardive syndromes is complex. Prognosis is frequently poor as patients usually need the o …
Comparison of dyskinesia profiles after L-DOPA dose challenges with or without dopamine agonist coadministration.
Grigoriou S, Espa E, Odin P, Timpka J, von Grothusen G, Jakobsson A, Cenci MA. Grigoriou S, et al. Neuropharmacology. 2023 Oct 1;237:109630. doi: 10.1016/j.neuropharm.2023.109630. Epub 2023 Jun 12. Neuropharmacology. 2023. PMID: 37315840 Free article.
Our results pave the way for the introduction of a combined l-DOPA-ropinirole challenge test in the early clinical evaluation of antidyskinetic treatments. Furthermore, we propose a machine-learning method to predict CDRS hyperkinesia severity using accelerometer data....
Our results pave the way for the introduction of a combined l-DOPA-ropinirole challenge test in the early clinical evaluation of antidyskine …
688 results